Next-generation therapies target the immune system to address Alzheimer’s disease and related disorders.
Non-neuronal brain cells and systemic immunity play a central role in Alzheimer’s disease (AD) and other brain disorders. The immune system, initially protective, becomes dysfunctional as the disease progresses. Here, we discuss next-generation therapeutic approaches aimed at treating the immune system rather than the brain to combat AD and other neurodegenerative diseases.
No takes yet. Share an insight, caveat, or question.
Schwartz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: